CD44 and lung carcinoma: Thus, the expression putative surface markers (CD44, CD133) of stem cells were analyzed in lung cancer cell lines using flow cytometry, where we found that the expression of them was reduced in the overexpressed SAV1 cells compared to the control (Fig. 6G).